Stocks · US
LH
XNYS
Labcorp Holdings Inc.
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E24.97x
P/B2.91x
P/S1.74x
EPS$12.36
ROE11.65%
ROA5.41%
Dividend yield0.96%
EV/EBITDA13.25x
Debt/Equity0.69
Free cash flow$1.2B
Returns and 52-week range
1W+0.94%
1M-4.64%
3M+12.23%
6M+15.80%
1Y+12.56%
YTD+23.86%
52W high$341.80
52W low$244.52
From 52W high-8.80%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| 가단트 헬스 | $25.1B | — | — | +5.75% |
| Incyte Genomics Inc | $23.1B | 14.35 | 3.65 | -11.06% |
| Royalty Pharma plc Class A Ordinary Shares | $25.2B | 30.96 | 3.69 | -11.76% |
| United Therapeutics Corp | $23.0B | 17.55 | 3.59 | +11.08% |
| 퀘스트 다이어그노스틱스 | $25.6B | 24.20 | 3.41 | -3.69% |
| Insmed, Inc. | $22.7B | — | 29.93 | -16.68% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.